arrow
D

David Bishop

Westmead Hospital
H指数:12
被引数:1,102

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL

缩短型axi-cel生产促进体内快速扩增并改变复发性/难治性LBCL的急性毒性特征

2026-08-180
OA
Harnessing single cell multi-omics data to identify predictors of clinical outcome in CD19 CAR T cell therapy

利用单细胞多组学数据确定CD19 CAR T细胞治疗中临床结果的预测因素

2024-03-220
PRE
CAR+ and CAR- T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies

在b细胞恶性肿瘤患者中,CD19 CAR T细胞输注后,CAR和car-t细胞共享分化为NK样亚群的轨迹

2023-11-279
OAAI
Combining CD34+stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant
2022-05-201
OA